Streetwise Company Fact Sheet2026/6/17 7:45:21
(SVA:TSX.V - SEOVF:OTC - PSH:XETRA)
Analyst coverage
| Leede Financial Inc. — Dr. Douglas Loe |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| Research Capital Corporation — Dr. Andre Uddin |
Newsletter coverage
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 03/05/2026 - View Article |
| 01/13/2026 - View Article |
| 07/15/2025 - View Article |
| 07/14/2025 - View Article |
| 07/10/2025 - View Article |
Streetwise - Sernova Biotherapeutics Inc. Ownership Overview*
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTC; PSH:XETRA)
Company News
6/17/2026 – Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
4/23/2026 – Sernova Biotherapeutics Announces Closing of Recently Approved Financings
3/24/2026 – Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
9/12/2024 – Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
